文献速递慢性肾脏病

银屑病与慢性肾脏病对全因死亡风险的交互作用:基于NHANES数据的前瞻性队列研究

Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality: a prospective cohort study of NHANES data.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该研究基于2003-06及2009-14年美国国家健康与营养调查(NHANES)的13208名参与者,采用加权Cox比例风险回归模型分析银屑病与慢性肾脏病(CKD)对全因死亡的联合影响。结果显示,同时患有银屑病和CKD者全因死亡风险显著升高(HR 5.38,95%CI 2.43-11.91),且银屑病与白蛋白尿存在显著协同效应(P=.002)。作者认为对CKD风险人群筛查银屑病可能有助于风险分层。

要点

  • 同时患银屑病和CKD者全因死亡风险为无二者者的5.38倍(95%CI 2.43-11.91)。
  • 银屑病合并白蛋白尿者全因死亡风险HR为5.30(95%CI 2.24-12.52)。
  • 银屑病与CKD对全因死亡存在显著交互作用(P=.026)。

核心结论

  • 对CKD风险人群筛查银屑病可能有助于银屑病相关全因死亡的风险分层,评估UACR可能有助于识别全因死亡风险升高的银屑病患者。

研究设计与样本

  • 前瞻性队列研究,纳入2003-06及2009-14年NHANES的13208名美国成年人。
  • 银屑病通过自报问卷确定,CKD定义为eGFR<60 mL/min/1.73 m2或UACR≥30 mg/g。
  • 采用Kaplan-Meier法估计生存概率,采用加权Cox比例风险回归模型进行生存分析。

主要发现

  • 平均随访9.83年期间发生539例死亡,CKD患者中银屑病患病率为2.94%,全因死亡率为33.30%。
  • 与既无银屑病也无CKD者相比,同时患银屑病和CKD者全因死亡HR为5.38(95%CI 2.43-11.91)。
  • 银屑病合并低eGFR者全因死亡HR为6.40(95%CI 2.01-20.42),银屑病合并白蛋白尿者HR为5.30(95%CI 2.24-12.52)。
  • 完全校正模型中银屑病与CKD对全因死亡的交互作用显著(P=.026),银屑病与白蛋白尿间存在显著协同效应(P=.002)。
  • 银屑病与低eGFR对全因死亡的交互作用仅在校正前模型中观察到(P=.036)。

临床怎么用

  • 作者认为,对CKD风险人群筛查银屑病可能有助于银屑病相关全因死亡的风险分层。
  • 作者认为,评估UACR可能有助于识别全因死亡风险升高的银屑病患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association between psoriasis, chronic kidney disease (CKD) and mortality remains unclear. This study aimed to examine the combined impact of psoriasis and CKD on mortality in a representative sample of US adults. METHODS: The data for this analysis came from 13 208 participants of the National Health and Nutrition Examination Survey conducted between 2003-06 and 2009-14. Psoriasis was determined through self-reported questionnaire data, while CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 or urinary albumin to creatinine ratio (UACR) ≥30 mg/g. A four-level variable was created using the information on psoriasis and CKD, and survival probability was estimated using the Kaplan-Meier method. The survival analysis was conducted using weighted Cox proportional hazards regression models. RESULTS: In a 9.83-year average follow-up period, 539 deaths occurred, with a prevalence of psoriasis in CKD at 2.94% and an all-cause mortality rate of 33.30%. In the multivariable analyses, individuals with both psoriasis and CKD had hazard ratios (HRs) of 5.38 (95% CI 2.43-11.91) for all-cause mortality compared with those with neither psoriasis nor CKD. Participants with both psoriasis and low eGFR had an HR of 6.40 (95% CI 2.01-20.42), while those with both psoriasis and albuminuria had an HR of 5.30 (95% CI 2.24-12.52). A significant interaction between psoriasis, CKD and all-cause mortality was found in the fully adjusted model (P = .026), and a significant synergistic effect between psoriasis and albuminuria was discovered (P = .002). However, the interaction effects between psoriasis, low eGFR and all-cause mortality were only observed in the unadjusted model (P = .036). CONCLUSIONS: Screening for psoriasis in individuals at risk for developing CKD may help in risk stratification for all-cause mortality related to psoriasis. The assessment of UACR may be useful in identifying psoriasis at increased risk for all-cause mortality.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lu J, Li H, Wang S, et al. Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality: a prospective cohort study of NHANES data. Nephrol Dial Transplant. 2023. PMID: 37173279. doi:10.1093/ndt/gfad089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。